UK and EU policy

News

People on a demo in America holding placards supporting science

Opinion | 4 December 2019

To secure investment, science must tell its story better by Ben Bleasdale

Number 12 bus outside the Houses of Parliament in London

Opinion | 11 November 2019

UK general election 2019: our letter to the party leaders by Jeremy Farrar

Photography display in the windows of Wellcome's HQ in London

Opinion | 22 October 2019

What accountability means to Wellcome by Mark Henderson

More news

Our work

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Emerging science and technologies

Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.

Data sharing in public health emergencies

Research is an essential part of being ready for and responding to public health emergencies.

Government investment in research

Government investment plays an important part in supporting scientific excellence in the UK.

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.

Reports

Report 21 March 2019 Updated 4 December 2019

A blueprint for dynamic oversight: how the UK can take a global lead in emerging science and technologies

DownloadPDF 720KB

Effective regulatory oversight is needed to make sure emerging science and technologies reach their full potential quickly and safely, and with the public's trust. Our report sets out how the UK can become a world leader in this area.

Report 21 March 2019 Updated 4 December 2019

A blueprint for the oversight of emerging science and technologies

[Summary] Effective regulatory oversight is needed to make sure emerging science and technologies reach their full potential quickly and safely, and with the public's trust. Our report sets out how the UK can become a world leader in this area.

Report 11 February 2019 Updated 4 December 2019

Regulation of clinical trials: Brexit and beyond

[Summary] Four realistic and achievable options for regulatory cooperation in UK-EU clinical trials, including costs and opportunities. 

More reports

Briefings and responses

Consultation response 1 June 2018 Updated 4 December 2019

An immigration system that works for science and innovation

DownloadPDF 568KB
Consultation response 1 May 2018 Updated 4 December 2019

Consultation on the future for food, farming and the environment

DownloadPDF 348KB
Consultation response 1 November 2017 Updated 5 December 2019

Science budget and Industrial Strategy inquiry

DownloadPDF 247KB
More briefings and responses